FDA Inspection
Rejuvenating Fertility CenterRejuvenating Fertility Center – FDA Inspection, Dec 23, 2025
Record Details
This FDA Inspection record concerns Rejuvenating Fertility Center, with an inspection on December 23, 2025, issued by the New York District Office, covering biologics.
View Company Profile
ID · dfb53602-0cef-443d-be5f-3a1cdbf7d093
Inspection Facts
- Inspection number
- 1286980
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.90(c)Eligibility not required--warning labels
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rejuvenating Fertility Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 9, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Rejuvenating Fertility Center
- FDA Inspection 1190305 - 2022-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.